vs
帕可Bio（PACB）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是RBB Bancorp的1.4倍（$44.6M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -90.4%，领先121.9%），帕可Bio同比增速更快（13.8% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $-19.9M），过去两年帕可Bio的营收复合增速更高（7.3% vs 7.0%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
PACB vs RBB — 直观对比
营收规模更大
PACB
是对方的1.4倍
$32.3M
营收增速更快
PACB
高出1.2%
12.6%
净利率更高
RBB
高出121.9%
-90.4%
自由现金流更多
RBB
多$62.5M
$-19.9M
两年增速更快
PACB
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $32.3M |
| 净利润 | $-40.4M | $10.2M |
| 毛利率 | 37.1% | — |
| 营业利润率 | -92.3% | 39.5% |
| 净利率 | -90.4% | 31.5% |
| 营收同比 | 13.8% | 12.6% |
| 净利润同比 | -1802.7% | 132.1% |
| 每股收益（稀释后） | $-0.11 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBRBB
| Q4 25 | $44.6M | $32.3M | ||
| Q3 25 | $38.4M | $32.6M | ||
| Q2 25 | $39.8M | $35.8M | ||
| Q1 25 | $37.2M | $28.5M | ||
| Q4 24 | $39.2M | $28.7M | ||
| Q3 24 | $40.0M | $30.3M | ||
| Q2 24 | $36.0M | $27.5M | ||
| Q1 24 | $38.8M | $28.2M |
净利润PACBRBB
| Q4 25 | $-40.4M | $10.2M | ||
| Q3 25 | $-38.0M | $10.1M | ||
| Q2 25 | $-41.9M | $9.3M | ||
| Q1 25 | $-426.1M | $2.3M | ||
| Q4 24 | $2.4M | $4.4M | ||
| Q3 24 | $-60.7M | $7.0M | ||
| Q2 24 | $-173.3M | $7.2M | ||
| Q1 24 | $-78.2M | $8.0M |
毛利率PACBRBB
| Q4 25 | 37.1% | — | ||
| Q3 25 | 41.4% | — | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 25.0% | — | ||
| Q2 24 | 16.5% | — | ||
| Q1 24 | 29.1% | — |
营业利润率PACBRBB
| Q4 25 | -92.3% | 39.5% | ||
| Q3 25 | -101.1% | 40.7% | ||
| Q2 25 | -112.8% | 36.1% | ||
| Q1 25 | -1154.5% | 11.2% | ||
| Q4 24 | -390.1% | 17.6% | ||
| Q3 24 | -160.3% | 31.6% | ||
| Q2 24 | -488.3% | 35.6% | ||
| Q1 24 | -209.6% | 39.9% |
净利率PACBRBB
| Q4 25 | -90.4% | 31.5% | ||
| Q3 25 | -98.9% | 31.2% | ||
| Q2 25 | -105.4% | 26.1% | ||
| Q1 25 | -1146.8% | 8.0% | ||
| Q4 24 | 6.0% | 15.3% | ||
| Q3 24 | -151.9% | 23.1% | ||
| Q2 24 | -481.3% | 26.4% | ||
| Q1 24 | -201.4% | 28.4% |
每股收益（稀释后）PACBRBB
| Q4 25 | $-0.11 | $0.59 | ||
| Q3 25 | $-0.13 | $0.59 | ||
| Q2 25 | $-0.14 | $0.52 | ||
| Q1 25 | $-1.44 | $0.13 | ||
| Q4 24 | $-0.44 | $0.26 | ||
| Q3 24 | $-0.22 | $0.39 | ||
| Q2 24 | $-0.64 | $0.39 | ||
| Q1 24 | $-0.29 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $5.3M | $523.4M |
| 总资产 | $784.1M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资PACBRBB
| Q4 25 | $279.5M | $212.3M | ||
| Q3 25 | $298.7M | $234.9M | ||
| Q2 25 | $314.7M | $191.9M | ||
| Q1 25 | $343.1M | $238.8M | ||
| Q4 24 | $389.9M | $257.7M | ||
| Q3 24 | $471.1M | $349.4M | ||
| Q2 24 | $509.8M | $252.8M | ||
| Q1 24 | $561.9M | — |
总债务PACBRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益PACBRBB
| Q4 25 | $5.3M | $523.4M | ||
| Q3 25 | $36.1M | $514.3M | ||
| Q2 25 | $61.5M | $517.7M | ||
| Q1 25 | $91.6M | $510.3M | ||
| Q4 24 | $506.6M | $507.9M | ||
| Q3 24 | $453.1M | $509.7M | ||
| Q2 24 | $492.7M | $511.3M | ||
| Q1 24 | $649.0M | $514.0M |
总资产PACBRBB
| Q4 25 | $784.1M | $4.2B | ||
| Q3 25 | $803.2M | $4.2B | ||
| Q2 25 | $825.5M | $4.1B | ||
| Q1 25 | $860.8M | $4.0B | ||
| Q4 24 | $1.3B | $4.0B | ||
| Q3 24 | $1.5B | $4.0B | ||
| Q2 24 | $1.5B | $3.9B | ||
| Q1 24 | $1.7B | $3.9B |
负债/权益比PACBRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $42.6M |
| 自由现金流率自由现金流/营收 | -44.6% | 131.8% |
| 资本支出强度资本支出/营收 | 1.9% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $73.5M |
8季度趋势，按日历期对齐
经营现金流PACBRBB
| Q4 25 | $-19.1M | $43.4M | ||
| Q3 25 | $-18.7M | $2.1M | ||
| Q2 25 | $-29.4M | $21.7M | ||
| Q1 25 | $-44.1M | $7.8M | ||
| Q4 24 | $-30.6M | $58.5M | ||
| Q3 24 | $-45.5M | $24.5M | ||
| Q2 24 | $-54.3M | $11.7M | ||
| Q1 24 | $-75.7M | $4.8M |
自由现金流PACBRBB
| Q4 25 | $-19.9M | $42.6M | ||
| Q3 25 | $-18.8M | $1.8M | ||
| Q2 25 | $-29.9M | $21.6M | ||
| Q1 25 | $-45.4M | $7.6M | ||
| Q4 24 | $-32.3M | $57.7M | ||
| Q3 24 | $-46.3M | $24.2M | ||
| Q2 24 | $-55.7M | $11.5M | ||
| Q1 24 | $-79.6M | $4.7M |
自由现金流率PACBRBB
| Q4 25 | -44.6% | 131.8% | ||
| Q3 25 | -48.9% | 5.4% | ||
| Q2 25 | -75.3% | 60.2% | ||
| Q1 25 | -122.3% | 26.7% | ||
| Q4 24 | -82.3% | 201.0% | ||
| Q3 24 | -115.7% | 80.0% | ||
| Q2 24 | -154.8% | 42.0% | ||
| Q1 24 | -205.0% | 16.6% |
资本支出强度PACBRBB
| Q4 25 | 1.9% | 2.5% | ||
| Q3 25 | 0.2% | 1.1% | ||
| Q2 25 | 1.4% | 0.3% | ||
| Q1 25 | 3.7% | 0.6% | ||
| Q4 24 | 4.1% | 2.7% | ||
| Q3 24 | 2.0% | 0.8% | ||
| Q2 24 | 4.1% | 0.5% | ||
| Q1 24 | 10.0% | 0.5% |
现金转化率PACBRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | -12.93× | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
RBB
暂无分部数据
